Founder's key components: IDH1/2, SDHA-D, FH, α-ketoglutarate Founder's description: "Central carbon metabolism whose intermediates (α-ketoglutarate, succinate, fumarate) also regulate the dioxygenase enzymes that control DNA and histone modification."
DRY status
DRY: none located. Query run: the single Russian plus English Filonov-tradition query listed under node 28. No DRY-modality TCA intermediate, flux or dioxygenase measurement was located. Dedicated TCA DRY queries and the nine non-English channels could not be run. Recorded NOT RUN.
Disconfirming first
D32.1. UNRESOLVED CONFLICT: blood TCA intermediates RISE with fasting, muscle TCA intermediates DO NOT MOVE. Both sides named. Blood, up: Teruya T, Chaleckis R, Takada J, Yanagida M, Kondoh H. Sci Rep 2019;9:854. DOI 10.1038/s41598-018-36674-9. 58 h fast, 4 subjects: roughly 2-fold increases in cis-aconitate, malate, 2-oxoglutarate and succinate. Muscle, flat: Bak AM et al. PLoS ONE 2018;13(9):e0200817. DOI 10.1371/journal.pone.0200817. 72 h fast versus 12 h, randomized crossover, 18 men: muscle citrate, succinate and malate were 20% to 45% lower in OBESE than LEAN, with NO EFFECT OF FASTING DURATION. The served text reports no p values for these. NAD+, NADH, NADP+, ATP, ADP and AMP were unaffected by fasting or BMI. Pyrophosphate and phosphate were unaffected. Not reconciled. The compartments differ (whole blood versus vastus lateralis), the durations differ (58 h versus 72 h), the sample sizes differ by more than four-fold (4 versus 18), and the designs differ (single-arm versus randomized crossover). The larger and better-designed study is the one that found nothing. No source opened ran both compartments in the same subjects. Reported unresolved.
D32.2. Anaplerosis into the TCA cycle did not rise from 12 h to 60 h of human fasting. Petersen KF, Dufour S, Cline GW, Shulman GI. J Clin Invest 2019;129(11):4671 to 4675. DOI 10.1172/JCI129913. Hepatic pyruvate carboxylase flux (VPC) essentially UNCHANGED at 60 h versus 12 h. Tier H3, modality PF.
D32.3. The n = 4 study that found the rises flags two of its own four subjects. Teruya 2019: volunteer 3's changes between 34 h and 58 h differed from volunteers 1 and 4 for reasons the authors did not explain, and volunteer 2 had a BMI of 16.86, which the authors note may have affected their response. Two of four subjects carry an author-stated caveat. Water intake was NOT monitored and physical activity was NOT monitored. This is why the row below is graded B and not B+.
Graded rows
32-R1. STRONGEST QUANTITATIVE HUMAN RESULT IN SLICE D. Hepatic mitochondrial oxidation falls about 50% between 12 h and 60 h of fasting, the pyruvate-carboxylase-to-citrate-synthase flux ratio rises about 90%, and an alanine infusion reverses both. Grade B+, tier H3, modality PF. Petersen KF, Dufour S, Cline GW, Shulman GI. "Regulation of hepatic mitochondrial oxidation by glucose-alanine cycling during starvation in humans." J Clin Invest 2019;129(11):4671 to 4675. DOI 10.1172/JCI129913. 20 healthy, lean, nonsmoking men recruited. Positional isotopomer NMR tracer analysis (PINTA) in 15 subjects after 12 h and 60 h fasts. Nine repeated the 60 h fast with alanine infusion. A separate 5 had alanine turnover measured at 12 h and 60 h. At 60 h versus 12 h:
- Hepatic mitochondrial oxidation, citrate synthase flux (VCS): about 50% LOWER.
- Hepatic pyruvate carboxylase flux (VPC): essentially UNCHANGED.
- VPC/VCS ratio: about 90% HIGHER.
- Beta-hydroxybutyrate to acetoacetate ratio, the hepatic redox index: about 3-fold higher in the Results and 3.4-fold in the Discussion. Both figures are in the paper; named, not reconciled.
- Plasma glucose and insulin: about 25% lower. Leptin and TSH about 50% lower. T3 and energy expenditure NOT changed.
- Alanine turnover about 425 micromol/min at 12 h, about 30% lower at 60 h, with no change in plasma alanine concentration.
Alanine infusion at 60 h, 5 micromol/kg/min, n = 9:
- EGP up about 30%. VPC up about 30%. VCS up about 70%. VPC/VCS down about 20%. Beta-OHB/AcAc significantly decreased.
Absolute values appear only in the paper's figures and were not readable; the percentages above are the text values. Retrieval debt R32.1. Cited inside the paper, not measured in it, tier A1: rats fasted 48 h, glucose-alanine cycling fell about 40%, plasma glucose about 6 mM to about 5 mM. Why this row is the strongest in the slice: it is a direct in vivo human measurement of mitochondrial oxidative FLUX in a named organ at two fasting time points, with an interventional arm inside the fasted state that moves the measured flux back in the predicted direction. Grade is B+ and not A because it is one laboratory, one cohort, within-subject, and no independent group has replicated it with the same method.
32-R2. Circulating organic acids roughly double over a 58 h fast, with succinate and cis-aconitate still rising at 58 h. Grade B, tier H3, modality PF. Teruya T, Chaleckis R, Takada J, Yanagida M, Kondoh H. "Diverse metabolic reactions activated during 58-hr fasting are revealed by non-targeted metabolomic analysis of human blood." Sci Rep 2019;9:854. DOI 10.1038/s41598-018-36674-9. Published 29 January 2019. 4 healthy, young, non-obese volunteers. Blood at 10, 34 and 58 h. No food or calories; calorie-free drinks allowed; water intake NOT monitored; physical activity NOT monitored. Fold changes in the text are generally 10 h versus 58 h.
- Roughly 2-fold increases in cis-aconitate, malate, 2-oxoglutarate and succinate.
- Citrate increased; the increase was previously reported and is confirmed, with no fold change in the text.
- Succinate and cis-aconitate kept rising until 58 h, while some metabolites peaked at 34 h.
- Aspartate DECREASED 0.4-fold at 58 h, similarly in all four volunteers; the authors suggest a malate-aspartate shuttle role.
- Whole-blood glucose stayed within 70 to 80 mg/dL across the fast.
- Fumarate is not mentioned. Lactate, pyruvate, glutamine, glutamate, serine and glycine are not reported in the content served.
Exact per-metabolite fold changes are in Table 1, Figure 4 and Supplementary Table S1, which the served page did not include, and a second read at character offset 100000 returned only license and footer material. Retrieval debt R32.2. See D32.1 and D32.3 for the conflict with muscle and the author-flagged subjects.
32-R3. 2-oxoglutarate signaling: the mechanism is established in cells, and there is no fasting experiment anywhere in the chain. Grade C, tier C1 and A1 for the mechanism, M for any fasting link. Green HLH, Brewer AC. "Dysregulation of 2-oxoglutarate-dependent dioxygenases by hyperglycaemia: does this link diabetes and vascular disease?" Clinical Epigenetics 2020;12:59. DOI 10.1186/s13148-020-00848-y.
- The 2-OGDD superfamily requires the tricarboxylic acid metabolite alpha-ketoglutarate and molecular oxygen as substrates, with Fe(II) as cofactor.
- TET1 to TET3 require 2-OG, O2 and Fe(II) for DNA demethylation.
- JmjC demethylases require 2-OG, O2 and Fe(II) for histone lysine demethylation. Named: JMJD1A, JMJD2B, JARID1B, KDM4A.
- HIF-PHD1 to PHD3 are named as the best-characterized 2-OGDDs and described as requiring molecular oxygen. The text does NOT explicitly list 2-OG for them, so this file does not claim it for them.
- FTO, ALKBH and collagen prolyl hydroxylases are NOT discussed in the retrieved content beyond a single link. No claim is made for them.
- Succinate and fumarate "strongly inhibited via steric competition of 2-OG." Evidence: knockdown of fumarate hydratase and succinate dehydrogenase in HEK293T cells (tier C1) and in mouse liver (tier A1) altered DNA and histone methylation.
- NO Km values for 2-OG and NO inhibition constants for succinate or fumarate are reported. The review mentions Km values for O2 only, without numbers.
- Related, not a fasting fact: high glucose raised succinate content in rat pancreatic islets by 40%.
THE INFERENCE, WRITTEN AS AN INFERENCE WITH ITS HOPS SHOWN, because the brief permits M rows and requires them to read as mechanism: Hop 1. A 58 h human fast roughly doubled BLOOD 2-oxoglutarate and roughly doubled blood succinate (Teruya 2019, n = 4). Both move, in opposite directions of effect on the same enzymes. Hop 2. 2-OG is a required substrate for TET and JmjC enzymes, and succinate competitively inhibits them (Green and Brewer 2020, cells and mouse liver). Therefore a fasting effect on DNA and histone methylation through this node is CONCEIVABLE and UNMEASURED. Hop 1 is a blood measurement, not an intracellular one, and the two intermediates that rose push the enzymes in opposite directions, so the net sign is not predictable from these data. Hop 2 contains no fasting intervention. This chain may not be written as a fasting effect on methylation. It is M.
32-R4. No human fasting measurement of IDH1/2, SDHA-D or FH was located. Tier M if written at all. The node's named enzymes are unmeasured under every fasting modality in everything located. Only the intermediates were measured.
Open questions, node 32
- The blood-versus-muscle conflict on TCA intermediates is open.
- Teruya 2019's exact fold changes are unread.
- Petersen 2019's absolute VCS and VPC values are unread (figure only).
- Fumarate under human fasting is unmeasured in everything opened.
- No human fasting study has measured a 2-OG-dependent dioxygenase product (5-hydroxymethylcytosine, a histone methylation mark, or a hydroxylated HIF substrate) alongside the TCA intermediates. Until one does, this node's signaling arm stays M.
← 31. De novo lipogenesis All 41 nodes 33. Oxidative phosphorylation →
dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.